| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/23/2010 | US7838211 detecting a compound capable of modulating the activity of an endoglycosidase having activity of the heparinase type, by measuring a signal resulting from a close proximity transfer between two compounds attached to a substrate for the enzyme |
| 11/23/2010 | US7838207 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease |
| 11/23/2010 | US7838036 beads with nucleic acids bound to surface; biochips; microfluidics, microelectromechanical systems |
| 11/23/2010 | US7838015 Adjuvanted meningococcus compositions |
| 11/23/2010 | US7838013 Specific epitope based immunological diagnosis of tuberculosis |
| 11/23/2010 | US7837946 valve comprises a deflectable elastomeric polydimethylsiloxane membrane for separating a microfluidic flow channel and a microfluidic control channel; conducting nucleic acid amplification reactions, genotyping and gene expression analyzes |
| 11/23/2010 | CA2458101C Van a and van b vancomycin resistant enterococci detection media and the method of detecting the organisms using the media |
| 11/23/2010 | CA2407899C Doped nanoparticles as biolabels |
| 11/23/2010 | CA2384355C Methods and means for modification of plant flowering characteristics |
| 11/23/2010 | CA2332560C A method of permanent fluorescent assay |
| 11/23/2010 | CA2315271C Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 11/23/2010 | CA2300192C Nucleic acid probes for detecting candida species |
| 11/23/2010 | CA2220293C Method to diagnose hereditary hemochromatosis |
| 11/23/2010 | CA2158791C Dna sequences encoding the machado-joseph disease gene and uses thereof |
| 11/19/2010 | CA2766319A1 Method and apparatus for diagnosing age-related macular degeneration |
| 11/18/2010 | WO2010132888A2 Methods and compositions relating to fusions of alk for diagnosing and treating cancer |
| 11/18/2010 | WO2010132886A1 Compositions and methods relating to xmrv-related diseases and conditions |
| 11/18/2010 | WO2010132866A1 Antipsychotic treatment based on drd2 or ankk1 snp genotype |
| 11/18/2010 | WO2010132861A2 Diagnostic and treatment for chronic and acute phase myeloid leukemia |
| 11/18/2010 | WO2010132832A1 E. coli o157:h7 specific assay |
| 11/18/2010 | WO2010132814A1 Long hepitype distribution (lhd) |
| 11/18/2010 | WO2010132805A2 System and method for automatically venting and sampling a culture specimen container |
| 11/18/2010 | WO2010132795A2 Systems, devices, and methods for specific capture and release of biological sample components |
| 11/18/2010 | WO2010132788A2 Assay for mutations in stem cells and their derivatives |
| 11/18/2010 | WO2010132780A2 System and method for agitation of multiple specimen containers |
| 11/18/2010 | WO2010132771A1 Methods and kits for measuring toxicity and oxidative stress in live cells |
| 11/18/2010 | WO2010132756A2 Sample processing cassette, system, and method |
| 11/18/2010 | WO2010132708A2 Modulation of terminase activity at telomeres and dna double-strand breaks |
| 11/18/2010 | WO2010132676A1 Methods for diagnosing chronic kidney disease and assessing the risk of disease progression |
| 11/18/2010 | WO2010132546A2 Sca risk stratification by predicting patient response to anti-arrhythmics |
| 11/18/2010 | WO2010132508A2 Compositions and methods for biological sample storage |
| 11/18/2010 | WO2010132486A2 Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 11/18/2010 | WO2010132479A2 Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 11/18/2010 | WO2010132453A2 Methods and compositions for analyte detection |
| 11/18/2010 | WO2010132097A2 Compositions and methods for pest control |
| 11/18/2010 | WO2010132054A1 Compositions and methods for immunodominant antigens of mycobacterium tuberculosis |
| 11/18/2010 | WO2010132019A1 Gene synthesis method |
| 11/18/2010 | WO2010131984A1 Markers for detection of gastric cancer |
| 11/18/2010 | WO2010131768A2 Dna marker unique to plant of erianthus spp. |
| 11/18/2010 | WO2010131748A1 Aptamer that recognizes peptide |
| 11/18/2010 | WO2010131704A1 Test agent for visceral obesity and use thereof |
| 11/18/2010 | WO2010131703A1 NOVEL PPARγ PROMOTER SEQUENCE AND USE APPLICATION THEREOF |
| 11/18/2010 | WO2010131641A1 Method for determination of condition of cell |
| 11/18/2010 | WO2010131491A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody |
| 11/18/2010 | WO2010131315A1 Induced mesenchymal stem cell and process for production thereof |
| 11/18/2010 | WO2010131268A1 Genetic variants for basal cell carcinoma, squamous cell carcinoma and cutaneous melanoma |
| 11/18/2010 | WO2010131195A1 Phosphodiesterase 4d7 as prostate cancer marker |
| 11/18/2010 | WO2010131194A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
| 11/18/2010 | WO2010131193A1 Phosphodiesterase 9a as prostate cancer marker |
| 11/18/2010 | WO2010130914A1 Method for detecting prokaryotic dna from a feces sample |
| 11/18/2010 | WO2010130882A1 A method and kit for detecting antibiotic resistant bacteria |
| 11/18/2010 | WO2010130877A2 Method for detecting nucleic acids |
| 11/18/2010 | WO2010130864A1 Modified reverse transcriptase of hiv-1 group o |
| 11/18/2010 | WO2010130833A1 Enzyme stabilization in electrochemical sensors |
| 11/18/2010 | WO2010130825A2 New targets for cancer therapy and/or diagnosis and new screening tools |
| 11/18/2010 | WO2010130809A1 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination |
| 11/18/2010 | WO2010130748A1 Method for identifying inhibitors against dengue virus |
| 11/18/2010 | WO2010130731A1 Hiv-1-c resistance monitoring |
| 11/18/2010 | WO2010130525A1 Biosensor for detecting toxins by means of a nucleic acid-coupled enzyme |
| 11/18/2010 | WO2010130447A1 Method for identifying interventions that control the translational activity of ribosomal proteins in differential mrna expression |
| 11/18/2010 | WO2010130351A1 Micrornas as biomarkers and therapeutic targets for heart failure |
| 11/18/2010 | WO2010130295A1 Methods for assessing the susceptibility of a human individual for narrowing of blood vessels after vascular intervention |
| 11/18/2010 | WO2010130053A1 COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGIC CANCERS TARGETING THE SIRPα - CD47 INTERACTION |
| 11/18/2010 | WO2010130030A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use |
| 11/18/2010 | WO2010105315A3 Reporter gene constructs for pet |
| 11/18/2010 | WO2010099468A3 Infertility associated defb-126 deletion polymorphism |
| 11/18/2010 | WO2010096036A3 Methods and kits for monitoring the effects of immunomodulators on adaptive immunity |
| 11/18/2010 | WO2010091406A3 Improvements in and relating to microfluidic devices for processing a sample |
| 11/18/2010 | WO2010090471A3 Novel diagnostic marker for type 1 diabetes mellitus |
| 11/18/2010 | WO2010088219A3 Reusable biosensor platform |
| 11/18/2010 | WO2010083250A3 Single-cell nucleic acid analysis |
| 11/18/2010 | WO2010080617A3 Detecting and sorting methylated dna using a synthetic nanopore |
| 11/18/2010 | WO2010075360A3 Methods for detection of sepsis |
| 11/18/2010 | WO2010065557A3 Methods of determining efficacy of glucocorticoid treatment of eosinophilic esophagitis |
| 11/18/2010 | WO2010065420A3 Universal biological sample processing |
| 11/18/2010 | WO2010056982A3 Compositions and methods for identifying autism spectrum disorders |
| 11/18/2010 | WO2010056351A3 Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia |
| 11/18/2010 | WO2010047561A3 Diagnostic kit for predicting the prognosis of invasive or non-muscle invasive bladder cancer, method for predicting the prognosis of bladder cancer, and bladder cancer medicine screening method |
| 11/18/2010 | WO2010025216A9 System and methods for measuring biomarker profiles |
| 11/18/2010 | WO2009146464A3 Methods and compositions for modifying levels of lignin and increasing the digestibility of cellulose by the recombinant overexpression of lignocellulolytic enzymes |
| 11/18/2010 | WO2009017743A3 Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides |
| 11/18/2010 | US20100293673 Compositions and Methods of Plant Breeding Using High Density Marker Information |
| 11/18/2010 | US20100293665 Plants With Increased Yield (KO NUE) |
| 11/18/2010 | US20100293628 ACETYL-CoA CARBOXYLASE HERBICIDE RESISTANT SORGHUM |
| 11/18/2010 | US20100292930 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 11/18/2010 | US20100292456 Rna interference mediating small rna molecules |
| 11/18/2010 | US20100292455 MODIFIED iRNA AGENTS |
| 11/18/2010 | US20100292452 Modified nucleotides |
| 11/18/2010 | US20100292451 Method for diagnosing selected adenocarcinomas |
| 11/18/2010 | US20100292339 Genetic Polymorphisms Predictive of Nutritional Requirements for Choline in Subjects |
| 11/18/2010 | US20100292331 Biomarkers for Prostate Cancer and Methods Using the Same |
| 11/18/2010 | US20100292308 Microrna molecules |
| 11/18/2010 | US20100292304 Compounds and methods for improving cellular uptake of oligomeric compounds |
| 11/18/2010 | US20100292303 Gene expression profile for predicting ovarian cancer patient survival |
| 11/18/2010 | US20100292302 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity |
| 11/18/2010 | US20100292300 Compositions and methods for inhibiting or reversing fibrotic disorders |
| 11/18/2010 | US20100292211 Antipsychotic treatment based on snp genotype |
| 11/18/2010 | US20100292181 Compositions and methods for detecting and treating hiv infections |
| 11/18/2010 | US20100292170 Methods for diagnosing and treating pelvic pain disorders via beta-catenin |
| 11/18/2010 | US20100292162 Socs-3 promoter methylation in cancer |